228 related articles for article (PubMed ID: 371395)
1. Renal transplantation for patients with type I and type II membranoproliferative glomerulonephritis: serial complement and nephritic factor measurements and the problem of recurrence of disease.
Curtis JJ; Wyatt RJ; Bhathena D; Lucas BA; Holland NH; Luke RG
Am J Med; 1979 Feb; 66(2):216-25. PubMed ID: 371395
[TBL] [Abstract][Full Text] [Related]
2. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
[TBL] [Abstract][Full Text] [Related]
3. Nephritic factor and recurrence in the renal transplant of membranoproliferative glomerulonephritis type II.
West CD; Bissler JJ
Pediatr Nephrol; 2008 Oct; 23(10):1867-76. PubMed ID: 18594868
[TBL] [Abstract][Full Text] [Related]
4. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
Lévy M; Sich M; Habib R
Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
[TBL] [Abstract][Full Text] [Related]
5. Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation.
Frémeaux-Bacchi V; Weiss L; Brun P; Kazatchkine MD
Nephrol Dial Transplant; 1994; 9(7):811-4. PubMed ID: 7970124
[TBL] [Abstract][Full Text] [Related]
6. Detection of C3bBb-stabilizing activity (C3 nephritic factor) in the serum from patients with membranoproliferative glomerulonephritis.
Ohi H; Watanabe S; Fujita T; Seki M; Hatano M
J Immunol Methods; 1990 Jul; 131(1):71-6. PubMed ID: 2380570
[TBL] [Abstract][Full Text] [Related]
7. [Complement activating factors in hypocomplementemic membranoproliferative glomerulonephritis (MPGN) patients' sera--comparison with C3NeF positive and negative cases].
Ohmori F; Ohi H; Seki M; Watanabe S; Hatano M
Nihon Jinzo Gakkai Shi; 1987 Apr; 29(4):493-8. PubMed ID: 3656707
[No Abstract] [Full Text] [Related]
8. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
Schena FP; Pertosa G; Stanziale P; Vox E; Pecoraro C; Andreucci VE
Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
[TBL] [Abstract][Full Text] [Related]
9. Classical complement pathway activation in membranoproliferative glomerulonephritis.
Ooi YM; Vallota EH; West CD
Kidney Int; 1976 Jan; 9(1):46-53. PubMed ID: 781380
[TBL] [Abstract][Full Text] [Related]
10. Transplantation in mesangiocapillary glomerulonephritis with intramembranous dense "deposits": recurrence of disease.
Turner DR; Cameron JS; Bewick M; Sharpstone P; Melcher D; Ogg CS; Evans DJ; Trafford AJ; Leibowitz
Kidney Int; 1976 May; 9(5):439-48. PubMed ID: 781388
[TBL] [Abstract][Full Text] [Related]
11. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
Ng YC; Peters DK
Clin Exp Immunol; 1986 Aug; 65(2):450-7. PubMed ID: 3641695
[TBL] [Abstract][Full Text] [Related]
12. Two types of C3 nephritic factor: properdin-dependent C3NeF and properdin-independent C3NeF.
Tanuma Y; Ohi H; Hatano M
Clin Immunol Immunopathol; 1990 Aug; 56(2):226-38. PubMed ID: 2143128
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of C3 nephritic factor and C4 nephritic factor in membranoproliferative glomerulonephritis (MPGN).
Ohi H; Yasugi T
Clin Exp Immunol; 1994 Feb; 95(2):316-21. PubMed ID: 8306508
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic rapidly progressive glomerulonephritis with C3 nephritic factor and hypocomplementemia.
Davis CA; McAdams AJ; Wyatt RJ; Forristal J; McEnery PT; West CD
J Pediatr; 1979 Apr; 94(4):559-63. PubMed ID: 372512
[TBL] [Abstract][Full Text] [Related]
15. [Direct detection C3bBb stabilizing activity in sera from hypocomplementaemic membranoproliferative glomerulonephritis (MPGN) and complement profiles of C3NeF positive cases].
Watanabe S; Ohi H; Seki M; Fujita T; Hatano M
Nihon Jinzo Gakkai Shi; 1985 Oct; 27(10):1345-52. PubMed ID: 4094159
[No Abstract] [Full Text] [Related]
16. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
Servais A; Frémeaux-Bacchi V; Lequintrec M; Salomon R; Blouin J; Knebelmann B; Grünfeld JP; Lesavre P; Noël LH; Fakhouri F
J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561
[TBL] [Abstract][Full Text] [Related]
17. C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.
Sethi S; Fervenza FC; Zhang Y; Zand L; Vrana JA; Nasr SH; Theis JD; Dogan A; Smith RJ
Kidney Int; 2012 Aug; 82(4):465-73. PubMed ID: 22673887
[TBL] [Abstract][Full Text] [Related]
18. Membranoproliferative glomerulonephritis type III: association of glomerular deposits with circulating nephritic factor-stabilized convertase.
West CD; McAdams AJ
Am J Kidney Dis; 1998 Jul; 32(1):56-63. PubMed ID: 9669425
[TBL] [Abstract][Full Text] [Related]
19. C5 measurement in membranoproliferative glomerulonephritis patients with C3 nephritic factor.
Ohi H; Watanabe S; Seki M; Fujita T; Ohmori F; Hatano M
Nephron; 1987; 46(2):217-8. PubMed ID: 3600936
[No Abstract] [Full Text] [Related]
20. Recurrence of dense deposits in transplanted kidney: II. Serum complement and nephritic factor profiles.
Leibowitch J; Halbwachs L; Wattel S; Gaillard MH; Droz D
Kidney Int; 1979 Apr; 15(4):396-403. PubMed ID: 390216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
